Journal Of Inflammation-london

Journal Title：Journal Of Inflammation-london

Journal of Inflammation welcomes research submissions on all aspects of inflammation.

The five classical symptoms of inflammation, namely redness (rubor), swelling (tumour), heat (calor), pain (dolor) and loss of function (functio laesa), are only part of the story. The term inflammation is taken to include the full range of underlying cellular and molecular mechanisms involved, not only in the production of the inflammatory responses but, more importantly in clinical terms, in the healing process as well. Thus the journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings.

Journal of Inflammation aims to become the leading online journal on inflammation and, as online journals replace printed ones over the next decade, the main open access inflammation journal. Open access guarantees a larger audience, and thus impact, than any restricted access equivalent, and increasingly so, as the escalating costs of printed journals puts them outside University budgets. The unrestricted access to research findings in inflammation aids in promoting dynamic and productive dialogue between industrial and academic members of the inflammation research community, which plays such an important part in the development of future generations of anti-inflammatory therapies.

《炎症杂志》欢迎有关炎症各个方面的研究投稿。

炎症的五种典型症状，即发红 (rubor)、肿胀 (tumour)、发热 (calor)、疼痛 (dolor) 和功能丧失 (functio laesa)，只是炎症的一部分。炎症一词涵盖了所涉及的所有潜在细胞和分子机制，不仅涉及炎症反应的产生，更重要的是，从临床角度来看，也涉及愈合过程。因此，该杂志涵盖了分子、细胞、动物和临床研究，以及药理学的相关方面，例如抗炎药物开发、试验和治疗发展。它还考虑发表负面发现。

《炎症杂志》旨在成为领先的炎症在线杂志，并且随着在线杂志在未来十年取代印刷杂志，成为主要的开放获取炎症杂志。与任何限制性访问相比，开放获取可以保证更大的受众，从而产生更大的影响，而且随着印刷期刊成本的不断上升超出大学预算，开放获取的影响力也越来越大。不受限制地获取炎症研究成果有助于促进炎症研究界的工业和学术成员之间进行动态和富有成效的对话，这对未来几代抗炎疗法的发展起着重要作用。

Journal Of Inflammation-london创刊于2004年，由BioMed Central出版商出版，收稿方向涵盖IMMUNOLOGY全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 12周，或约稿 ，影响因子指数4.4，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。